证券之星消息，截至2025年11月13日收盘，中 关 村(000931)报收于5.44元，上涨0.55%，换手率 1.03%，成交量7.72万手，成交额4183.72万元。 11月13日的资金流向数据方面，主力资金净流出106.54万元，占总成交额2.55%，游资资金净流入31.09 万元，占总成交额0.74%，散户资金净流入75.45万元，占总成交额1.8%。 近5日资金流向一览见下表： | | | | | 日期 收盘价 涨跌幅 主力净流入 主力净占比 游资净齿比 散户净流入 散户净占比 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 2025-11-13 | 5.44 0.55% | | -106.54万 | -2.55% | 31.09万 | 0.74% | 75.45万 | 1.80% | | 2025-11-12 | 5.41 | -0.18% | -1128.08万 | -21.57% | 40.72万 | 0.78% | 1087.36万 | 20.79% | | 2025-11-11 | | 5.42 0. ...

Core Viewpoint - The stock of Zhongguancun (000931) has shown a slight increase, with a closing price of 5.32 yuan on September 5, 2025, reflecting a 0.76% rise, amidst mixed capital flows from different investor types [1] Group 1: Stock Performance and Capital Flow - On September 5, 2025, the stock recorded a trading volume of 101,100 hands and a transaction amount of 53.33 million yuan [1] - The net inflow of main funds was 3.63 million yuan, accounting for 6.8% of the total transaction amount, while retail investors experienced a net outflow of 3.25 million yuan, representing 6.1% of the total [1] - Over the past five days, the stock's closing prices fluctuated, with a peak of 5.35 yuan and a low of 5.21 yuan, indicating volatility in investor sentiment [2] Group 2: Financial Metrics and Industry Comparison - Zhongguancun's total market value is 4.007 billion yuan, significantly lower than the industry average of 16.321 billion yuan, ranking 114th out of 146 in the chemical pharmaceutical sector [3] - The company reported a net profit of 38.81 million yuan for the first half of 2025, a 6.65% increase year-on-year, despite a 2.71% decline in main revenue to 1.239 billion yuan [3] - The gross profit margin stands at 60.8%, which is higher than the industry average of 49.61%, indicating strong profitability relative to peers [3] Group 3: Business Segments - Zhongguancun operates in several business segments, including biopharmaceuticals, health products, elderly care services, and commercial concrete, with a focus on research, manufacturing, and sales of various pharmaceutical forms and medical devices [3]